Leap Therapeutics (LPTX) Short Interest Ratio & Short Volume → Don’t make this retirement mistake (From Sasco Gold LLC) (Ad) Free LPTX Stock Alerts $2.25 -0.04 (-1.75%) (As of 06/11/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Leap Therapeutics Short Interest DataCurrent Short Interest1,350,000 sharesPrevious Short Interest1,360,000 sharesChange Vs. Previous Month-0.74%Dollar Volume Sold Short$3.78 millionShort Interest Ratio4.4 Days to CoverLast Record DateMay 15, 2024Outstanding Shares25,600,000 sharesFloat Size25,510,000 sharesShort Percent of Float5.29%Today's Trading Volume128,621 sharesAverage Trading Volume279,431 sharesToday's Volume Vs. Average46% Short Selling Leap Therapeutics ? Sign up to receive the latest short interest report for Leap Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartLPTX Short Interest Over TimeLPTX Days to Cover Over TimeLPTX Percentage of Float Shorted Over Time Ad Sasco Gold LLCDON’T buy gold until you read thisIf you're an American who understands that your money is rotting away as you read this email… Then this is for YOU. 99% of people are buying gold the wrong way.Reserve your seat here. Leap Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20241,350,000 shares $3.78 million -0.7%5.3%4.4 $2.80 4/30/20241,360,000 shares $4.22 million -6.2%5.6%4.5 $3.10 4/15/20241,450,000 shares $4.35 million +27.2%6.2%4.5 $3.00 3/31/20241,140,000 shares $3.03 million +0.9%4.9%4.7 $2.66 3/15/20241,130,000 shares $2.50 million -3.4%4.8%4.4 $2.21 2/29/20241,170,000 shares $3.26 million +4.5%5.0%4.4 $2.79 Get the Latest News and Ratings for LPTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Leap Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/20241,120,000 shares $3.66 million +74.8%4.8%4 $3.27 1/31/2024640,800 shares $1.92 million +7.3%2.7%2.2 $3.00 1/15/2024597,400 shares $2.10 million +5.3%2.5%2.3 $3.51 12/31/2023567,300 shares $2.35 million +2.9%2.4%2.4 $4.15 12/15/2023551,200 shares $1.67 million -2.2%2.4%1.8 $3.03 11/30/2023563,600 shares $1.27 million -29.4%2.4%2 $2.25 11/15/2023798,100 shares $1.28 million +7.2%3.4%2.9 $1.60 10/31/2023744,200 shares $1.09 million +24.6%3.2%3.1 $1.47 10/15/2023597,500 shares $908,200.00 -15.1%2.5%2 $1.52 9/30/2023703,400 shares $970,692.00 +2.7%3.0%2.1 $1.38 9/15/2023684,800 shares $1.08 million +1.9%2.9%2.7 $1.57 8/31/2023671,800 shares $1.50 million -3.2%3.2%2.6 $2.23 8/15/2023694,300 shares $1.76 million -5.3%3.3%2.7 $2.54 7/31/2023732,800 shares $2.01 million -36.3%7.5%2.9 $2.74 7/15/20231,150,000 shares $3.62 million +3.6%12.0%6.4 $3.15 6/30/20231,110,000 shares $3.47 million +6.7%11.6%7.9 $3.13 6/15/20231,040,000 shares $6.29 million -89.8%10.8%8.6 $6.05 5/31/202310,230,000 shares $9.10 million -11.2%N/A10.5 $0.89 5/15/202311,520,000 shares $5.18 million +0.1%N/A14.7 $0.45 4/30/202311,510,000 shares $4.50 million No ChangeN/A19.4 $0.39 4/15/202311,510,000 shares $4.52 million +1.1%N/A16.3 $0.39 3/31/202311,390,000 shares $3.87 million +20.0%N/A15.8 $0.34 3/15/20239,490,000 shares $3.92 million +5.8%N/A12.2 $0.41 2/28/20238,970,000 shares $5.11 million +45.2%N/A12.3 $0.57 2/15/20236,180,000 shares $3.72 million +22.1%N/A8.5 $0.60 1/31/20235,060,000 shares $3.36 million +15.0%N/A6.2 $0.67 1/15/20234,400,000 shares $2.56 million +57.1%N/A5.5 $0.58 12/30/20222,800,000 shares $1.26 million +27.3%N/A4.6 $0.45 12/15/20222,200,000 shares $1.10 million -1.4%N/A3.9 $0.50 11/30/20222,230,000 shares $1.35 million -6.3%N/A3.6 $0.60 11/15/20222,380,000 shares $1.67 million -32.6%N/A3.5 $0.70 10/31/20223,530,000 shares $3.00 million +10.3%N/A5.1 $0.85 10/15/20223,200,000 shares $2.82 million +10.7%N/A5.3 $0.88 9/30/20222,890,000 shares $2.54 million +10.7%N/A4.7 $0.88Don’t make this retirement mistake (Ad)If you have over $100,000 in your 401K or IRA… Then listen closely… Your money is rotting away, and you might not even realize it.Reserve your seat here. 9/15/20222,610,000 shares $3.08 million No ChangeN/A3.9 $1.18 8/31/20222,610,000 shares $3.71 million +6.5%N/A4.1 $1.42 8/15/20222,450,000 shares $3.50 million -70.6%N/A3.9 $1.43 7/31/20228,340,000 shares $8.67 million -37.4%N/A12.1 $1.04 7/15/202213,320,000 shares $14.52 million -1.4%N/A18.1 $1.09 6/30/202213,510,000 shares $15.54 million -1.0%N/A17 $1.15 6/15/202213,650,000 shares $13.92 million -1.1%N/A17.2 $1.02 5/31/202213,800,000 shares $14.90 million -1.9%N/A17.8 $1.08 5/15/202214,070,000 shares $18.43 million No ChangeN/A18.7 $1.31 4/30/202214,070,000 shares $18.15 million +1.2%N/A17.3 $1.29 4/15/202213,910,000 shares $22.12 million -0.1%N/A13.6 $1.59 3/31/202213,930,000 shares $24.38 million +0.4%N/A10.7 $1.75 3/15/202213,880,000 shares $23.32 million No ChangeN/A8.8 $1.68 2/28/202213,880,000 shares $27.62 million -2.3%N/A8 $1.99 2/15/202214,200,000 shares $34.08 million +4.1%N/A7.4 $2.40 1/31/202213,640,000 shares $26.46 million -8.1%N/A7 $1.94 1/15/202214,840,000 shares $42.15 million +12.9%N/A7.7 $2.84 12/31/202113,150,000 shares $42.61 million +12.9%N/A6.7 $3.24 12/15/202111,650,000 shares $29.13 million +12.8%N/A4.3 $2.50 11/30/202110,330,000 shares $26.96 million +3.8%N/A1.6 $2.61 11/15/20219,950,000 shares $23.88 million -5.8%N/A1.6 $2.40 10/29/202110,560,000 shares $29.46 million -1.5%N/A1.7 $2.79 10/15/202110,720,000 shares $33.77 million -6.1%N/A1.8 $3.15 9/30/202111,410,000 shares $45.75 million +152.4%N/A2.1 $4.01 9/15/20214,520,000 shares $8.72 million +99.1%9.8%1 $1.93 8/31/20212,270,000 shares $3.90 million +33.5%4.9%4 $1.72 8/13/20211,700,000 shares $2.86 million +39.3%3.7%4.3 $1.68 7/30/20211,220,000 shares $1.73 million -0.8%2.7%3.4 $1.42 7/15/20211,230,000 shares $1.72 million -2.4%2.7%4.1 $1.40 6/30/20211,260,000 shares $2.07 million +2.4%2.8%3.6 $1.64 6/15/20211,230,000 shares $2.19 million +8.9%2.7%3.1 $1.78 5/28/20211,130,000 shares $1.83 million -4.2%2.5%2 $1.62 5/14/20211,180,000 shares $1.75 million -21.9%N/A2 $1.48 4/30/20211,510,000 shares $2.57 million +2.7%N/A2 $1.70 4/15/20211,470,000 shares $2.56 million -7.6%N/A1.7 $1.74 3/31/20211,590,000 shares $2.93 million +12.0%N/A1.8 $1.84 3/15/20211,420,000 shares $3.39 million +16.4%N/A1.3 $2.39 2/26/20211,220,000 shares $3.00 million +15.1%N/A1.2 $2.46 2/12/20211,060,000 shares $2.92 million +13.7%N/A1.1 $2.75 1/29/2021932,600 shares $2.15 million -23.6%N/A0.9 $2.31 1/15/20211,220,000 shares $2.71 million +13.0%N/A1.3 $2.22 12/31/20201,080,000 shares $2.39 million +38.8%N/A1.2 $2.21 12/15/2020778,400 shares $1.43 million +24.3%N/A0.9 $1.84 11/30/2020626,300 shares $995,817.00 +8.2%N/A1 $1.59 11/15/2020579,000 shares $926,400.00 +3.0%N/A1 $1.60 10/30/2020562,200 shares $1.11 million +4.6%N/A1.1 $1.98 10/15/2020537,700 shares $1.15 million -34.6%N/A1.1 $2.13 9/30/2020821,800 shares $1.63 million -5.3%N/A1.2 $1.98 9/15/2020868,100 shares $1.66 million +6.3%N/A1.1 $1.91 8/31/2020816,400 shares $1.42 million -10.2%N/A0.9 $1.74Don’t make this retirement mistake (Ad)If you have over $100,000 in your 401K or IRA… Then listen closely… Your money is rotting away, and you might not even realize it.Reserve your seat here. 8/14/2020908,900 shares $1.73 million -13.4%N/A1 $1.90 7/31/20201,050,000 shares $2.15 million -16.0%N/A1.2 $2.05 7/15/20201,250,000 shares $2.26 million +5.0%N/A1.6 $1.81 6/30/20201,190,000 shares $2.59 million -16.8%N/A2.2 $2.18 6/15/20201,430,000 shares $3.62 million +5.2%N/A3.3 $2.53 5/29/20201,360,000 shares $3.22 million -2.9%6.4%4.7 $2.37 5/15/20201,400,000 shares $3.21 million -2.1%6.6%4.3 $2.29 4/30/20201,430,000 shares $3.13 million +32.4%6.7%3.3 $2.19 4/15/20201,080,000 shares $1.92 million -4.4%5.1%2 $1.78 3/31/20201,130,000 shares $2.71 million -35.2%5.3%1.9 $2.40 3/13/20201,742,400 shares $2.94 million -5.3%12.0%3.2 $1.69 2/28/20201,840,000 shares $2.41 million +21.9%12.7%2.2 $1.31 2/14/20201,510,000 shares $3.35 million -7.9%10.4%1.9 $2.22 1/31/20201,640,000 shares $4.41 million +41.4%11.3%2.4 $2.69 1/15/20201,160,000 shares $2.47 million +23.1%8.0%1.8 $2.13 12/31/2019942,100 shares $1.79 million +1.9%6.5%1.8 $1.90 LPTX Short Interest - Frequently Asked Questions What is Leap Therapeutics' current short interest? Short interest is the volume of Leap Therapeutics shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 1,350,000 shares of LPTX short. 5.29% of Leap Therapeutics' shares are currently sold short. Learn More on Leap Therapeutics' current short interest. What is a good short interest ratio for Leap Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LPTX shares currently have a short interest ratio of 4.0. Learn More on Leap Therapeutics's short interest ratio. What is a good short interest percentage for Leap Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.29% of Leap Therapeutics' floating shares are currently sold short. Is Leap Therapeutics' short interest increasing or decreasing? Leap Therapeutics saw a decline in short interest in the month of May. As of May 15th, there was short interest totaling 1,350,000 shares, a decline of 0.7% from the previous total of 1,360,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Leap Therapeutics' float size? Leap Therapeutics currently has issued a total of 25,600,000 shares. Some of Leap Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Leap Therapeutics currently has a public float of 25,510,000 shares. How does Leap Therapeutics' short interest compare to its competitors? 5.29% of Leap Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Leap Therapeutics: ProPhase Labs, Inc. (1.36%), Tonix Pharmaceuticals Holding Corp. (0.82%), Eliem Therapeutics, Inc. (0.66%), Akebia Therapeutics, Inc. (5.58%), Rani Therapeutics Holdings, Inc. (7.54%), Adlai Nortye Ltd. (0.03%), Design Therapeutics, Inc. (8.59%), Acrivon Therapeutics, Inc. (4.79%), XBiotech Inc. (3.65%), 2seventy bio, Inc. (13.22%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Leap Therapeutics stock? Short selling LPTX is an investing strategy that aims to generate trading profit from Leap Therapeutics as its price is falling. LPTX shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Leap Therapeutics? A short squeeze for Leap Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LPTX, which in turn drives the price of the stock up even further. How often is Leap Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LPTX, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ProPhase Labs Short Interest Tonix Pharmaceuticals Short Interest Eliem Therapeutics Short Interest Akebia Therapeutics Short Interest Rani Therapeutics Short Interest Adlai Nortye Short Interest Design Therapeutics Short Interest Acrivon Therapeutics Short Interest XBiotech Short Interest 2seventy bio Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LPTX) was last updated on 6/11/2024 by MarketBeat.com Staff From Our PartnersNVDA to close the AI “wealth window’ June 25?On Tuesday, June 25, in front of executives from nearly every major tech company in existence, key leaders at ...Paradigm Direct | SponsoredDON’T buy gold until you read thisIf you're an American who understands that your money is rotting away as you read this email… Then this is ...Sasco Gold LLC | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredA once-in-a-century investment opportunityIt's an under-the-radar stock reshaping a projected $109 billion industry - And, I believe, has far more poten...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Leap Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Leap Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.